Mood disorders in multiple sclerosis: Diagnosis and treatment

Journal of NeuroVirology

Volumn 6, Issue SUPPL. 2, 2000, Pages

  Minden, S L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Affective disorders; Depression; Euphoria; Mood disorders; Multiple sclerosis; Pathological laughing and weeping

Indexed keywords

AFFECTIVE NEUROSIS; ANXIETY NEUROSIS; CONFERENCE PAPER; DEPRESSION; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; MULTIPLE SCLEROSIS; PANIC; PRIORITY JOURNAL;

HUMANS; MOOD DISORDERS; MULTIPLE SCLEROSIS;

EUPHORIA;

EID: 0034080440     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (121)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington, DC.
2. Andreatini R, Sartori VA, Leslie JR, Oliveira ASB (1994). Panic attacks in a multiple sclerosis patient. Biol Psychiatry 35: 133-134.
3. Areas Bal MA, Vazquez-Barquero JL, Pena C, Berciano JA (1991). Psychiatric aspects of multiple sclerosis. Act Psychiatr Scand 83: 292-296.
4. Baldwin MV (1952). A clinico-experimental investigation into the psychologic aspects of multiple sclerosis. J Nerv Ment Dis 115: 299-342.
5. Barak Y, Achiron A, Elizur A, Gabbay U, Noy S, Sarova-Pinhas I (1996). Sexual dysfunction in relapsing-remitting multiple sclerosis: magnetic resonance imaging, clinical, and psychological correlates. J Psychiatry Neurosci 21: 255-258.
6. Bates A, Burns DD, Moorey S (1989). Medical illness and the acceptance of suffering. Int J Psychiatry Med 19: 269-280.
7. Black DW (1982). Pathologic laughter: a review of the literature. J Nerv Ment Dis 170: 67-71.
8. Braceland FJ, Giffin ME (1950). The mental changes associated with multiple sclerosis (an interim report). Res Publ Assoc Nerv Ment Dis 28: 450-455.
9. Browning WN (1990). Exacerbation of symptoms of multiple sclerosis in a patient taking fluoxetine [letter]. Am J Psychiatry 147: 1089.
10. Cass LJ, Alexander L, Enders M (1966). Complications of corticotropin therapy in multiple sclerosis. JAMA 197: 105-111.
11. Cazzullo CL, Smeraldi E, Gasperini M, Caputo D (1983). Preliminary correlation between primary affective disorders and multiple sclerosis. In: New Trends in Multiple Sclerosis Research. Cazzullo CL, Caputo D, Ghezzi A (eds). Masson Publishing USA Inc: New York, pp. 57-62.
12. Clark CM, Fleming JA, Li D, Oger J, Klonoff H, Paty D (1992a). Sleep disturbance, depression, and lesion site in patients with multiple sclerosis. Arch Neurol 49: 641-643.
13. Clark CM, James G, Li D, Oger J, Paty D, Klonoff H (1992b). Ventricular size, cognitive function and depression in patients with multiple sclerosis. Can J Neurol Sci 19: 352-356.
14. Cleeland CS, Matthews CG, Hopper CL (1970). MMPI profiles in exacerbation and remission of multiple sclerosis. Psychol Rep 41: 373-374.
15. Cohen-Cole S, Friedman C (1982). Attitudes of non-psychiatric physicians toward psychiatric consultation. Hospital Community Psychiatry 33: 1002-1006.
16. Cottrell SS, Wilson SAK (1926). The affective symptomatology of disseminated sclerosis. J Neurol Psychopathol 7: 1-30.
17. Crawford JD, McIvor GP (1985). Group psychotherapy: benefits in multiple sclerosis. Arch Phys Med Rehabil 66: 810-813.
18. Dalos NP, Rabins PV, Brooks BR, O'Donnell P (1983). Disease activity and emotional state in multiple sclerosis. Ann Neurol 13: 573-583.
19. DeLuca J, Johnson SK, Natelson BH (1993). Information processing efficiency in chronic fatigue syndrome and multiple sclerosis. Arch Neurol 50: 301-304.
20. Depression Guideline Panel (1993a). Depression in primary care: Vol 2. Detection and diagnosis. Clinical Practice Guideline. No. 5, AHCPR Pub. No. 93-0550. U.S. Department of Health and Human Services, Public Health Service. Agency for Health Care Policy and Research: Rockville, MD.
21. Depression Guideline Panel (1993b). Depression in primary care: Vol 2. Treatment of major depression. Clinical Practice Guideline, No. 5, AHCPR Pub. No. 93-0551. (U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research: Rockville, MD.
22. Devins GM, Edworthy SM, Paul LC, Manin H, Seland TP, Klein G, Costello CG, Shapiro CM (1993). Restless sleep, illness intrusiveness, and depressive symptoms in three chronic illness conditions: rheumatoid arthritis, end-stage renal disease, and multiple sclerosis. J Psychosom Res 37: 163-170.
23. Falk WE, Mahnke MW, Poskanzer DC (1979). Lithium prophylaxis of corticotropin-induced psychosis. JAWA 241: 1011-1012.
24. Fassbender K, Schmidt R, Mossner R, Kischka U, Kuhnen J, Schwartz A, Hennerici M (1998). Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation. Arch Neurol 55: 66-72.
25. Feinstein A, Feinstein K, Gray T, O'Connor P (1997). Prevalence and neurobehavioral correlates of pathological laughing and crying in multiple sclerosis. Arch Neurol 54: 1116-1121.
26. Filippi M, Alveroni M, Martinelli V, Sirabian G, Bresi S, Canal N, Comi G (1994). Influence of clinical vvariables on neuropsychological perforamcne in multiple sclerosis. Eur Neurol 34: 324-328.
27. Fisk JD, Morehouse SA, Brown MG, Skedgel C, Murray TJ (1998). Hospital-based psychiatric service utilization and morbidity in multiple sclerosis. Can J Neurol Sci 25: 230-235.
28. Flax JW, Gray J, Herbert J (1991). Effect of fluoxetine on patients with multiple sclerosis [letter]. Am J Psychiatry 148: 1603.
29. Foley FW, Traugott U, LaRocca NG, Smith CR, Perlman KR, Caruso LS, Scheinberg LC (1992). A prospective study of depression and immune dysregulation in multiple sclerosis. Arch Neurol 49: 238-244.
30. Garfield DAS (1985). Multiple sclerosis and affective disorders: 2 cases of mania with psychosis. Psychother Psychosom 44: 22-33.
31. Gelenberg AJ, Bassuk EL (1997). The Practitioner's Guide to Psychoactive Drugs, 4th edn. Plenum Medical Book Company: New York.
32. George MS, Kellner CH, Berstein H, Goust JM (1994). A magnetic resonance imagining investigation into mood disorders in multiple sclerosis: a pilot study. J Nerv Ment Dis 182: 410-412.
33. Gerber P, Barrett J, Barrett J, Manheimer E, Whiting R, Smith R (1989). Recognition of depression by internists in primary care: A comparison of internist and 'gold standard', psychiatric assessments. J Gen Intern Med 4: 7-13.
34. Gilchrist AC, Creed FH (1994). Depression, cognitive impairment and social stress in multiple sclerosis. J Pscyhosom Res 38: 193-201.
35. Gonzalez CF, Swirsky-Sacchetti T, Mitchell D, Lublin FD, Knobler RL, Ehrlich SM (1994). Distributional patterns of multiple sclerosis brain lesions. Magnetic resonance imaging - clinical correlation. J Neuroimag 4: 188-195.
36. Hartings MF, Pavlou MM, Davis FA (1976). Group counseling of MS patients. J Chron Dis 29: 65-73.
37. Honer WG, Hurwitz Y, Li DKB (1987). Temporal lobe involvement in multiple sclerosis patients with psychiatric disorders. Arch Neurol 447: 187-190.
38. Hornig-Rohan M, Amsterdam JD (1996). Treatment-resistent Depression. Psychiat Clin North Am 19: 1-412.
39. Hotoff MH, Pollock S, Lishman WA (1994). An unusual presentation of multiple sclerosis. Psychol Med 24: 525-528.
40. Iannaccone S, Ferini-Strambi L (1996). Pharmacologic treatment of emotional lability. Clin Neuropharmacol 19: 532-535.
41. Ironside R (1956). Disorders of laughter due to brain lesions. Brain 79: 589-609.
42. Joffe RT, Lipppert GP, Gray TA, Sawa G, Horvath Z (1987). Mood disorder and multiple sclerosis. Arch Neurol 44: 376-378.
43. Johnson SK, DeLuca J, Natelson BH (1996). Depression in fatiguing illness: comparing ptients with chronic fatigue syndrome, multiple sclerosis and depression. J Affect Disord 39: 21-30.
44. Kahana E, Leibowitz U, Alter M (1971). Cerebral multiple sclerosis. Neurology 21: 1179-1185.
45. Keller MB (1996). Mood Disorders. Psychiat Clin North Am 19: 1-178.
46. Kellner CH, Davenport Y, Post RM, Ross RJ (1982). Rapidly cycling bipolar disorder and multiple sclerosis. Am J Psychiatry 141: 112-113.
47. Kemp K, Lion JR, Magram G (977). Lithium in the treatment of a manic patinet with multiple sclerosis a case report. Dis Nerv Syst 38: 210-211.
48. Krupp LB, Sliwinski M, Masur DM, Friedberg F, Coyle PK (1994). Cognitive functioning and depression in patients with chronic fatigue syndrome and multiple sclerosis. Arch Neurol 51: 705-710.
49. Langworthy OR, Hesser FH (1940). Syndrome of pseudobulbar palsy: an anatomic and physiologic analysis. Arch Intern Med 65: 106-121.
50. Langworthy OR, Kolb LC, Androp S (1941). Disturbances of behavior in patients with disseminated sclerosis. Am J Psychiatry 98: 243-249.
51. Laracombe NA, Wilson PH (1984). An evaluation of cognitive-behavior therapy for depression in patients with multiple sclerosis. Br J Psychiatr 145: 366-371.
52. Mapelli G, Ramelli E (1981). Manic syndrome associated with multiple sclerosis: secondary mania? Acta Pscychiatr Scan 81: 337-349.
53. Matthews B (1979). Multiple sclerosis presenting with acute remitting psychiatric symptoms. Neurol Neurosurg Psychiatry 42: 859-863.
54. McIvor GP, Riklan M, Reznikoff M (1984). Depression in multiple sclerosis as a function of length and severity of illness, age, remissions, and perceived social support. J Clin Psychol 40: 1028-1033.
55. Mendez MF (1995). The neuropsychiatry of multiple sclerosis. Int J Psychiatry Med 25: 123-130.
56. Minden SL, Schiffer RB (1990). Affective disorders in multiple sclerosis. Review and recommendations for clinical research. Arch Neurol 47: 98-104.
57. Minden SL, Marder W (1993). Multiple Sclerosis: A Statistical Portrait. A compendium of data on demographics, disability, and health services utilization in the United States. Report to the National Multiple Sclerosis Society.
58. Minden SL (1996). Neuropsychiatric aspects of multiple sclerosis. Curr Opin Psychiatry 9: 93-97.
59. Minden SL, Orav J, Reich P (1987). Depression in multiple sclerosis. Gen Hosp Psychiatry 9: 426-434.
60. Minden SL, Orav J, Schildkraut JJ (1988). Hypomanic reastions to ACTH and prednisone treatment for multiple sclerosis. Neurology 38: 1631-1634
61. Minden SL (1992). Psychotherapy for people with multiple sclerosis. Neuropsychiatry Clin Neurosci 4: 1-16.
62. Mohr DC, Goodkin DE, Gatto N, Van der Wende J (1997a). Depression, coping and level of neurological impairment in multiple sclerosis. Mult Sclerosis 3: 254-258.
63. Mohr DC, Goodkin DE, Likosky W, Beutler L, Gatto N, Langan MK (1997b). Identification of Beck Depression Inventory items related to multiple sclerosis. J Behav Med 20: 407-414.
64. Mohr DC, Goodkin DE, Likosky W, Gatto N, Baumann KA, Rudick RA (1997c). Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch Neurol 54: 531-533.
65. Moller A, Wiedman G, Rohde U, Backmund H, Sonntag A (1994). Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis. Acta Psychiatr Scand 89: 117-121.
66. Natelson BH, Johnson SK, DeLuca J, Sisto S, Ellis SP, Hill N, Bergen MT (1995). Reducing heterogeneity in chronic fatigue syndrome: a comparison with depression and multiple sclerosis. Clin Infect Dis 21: 1204-1210.
67. Noy S, Achiron A, Gabbay U, Barak Y, Rotstein Z, Laor N, Sarova-Pinhas I (1995). A new approach to affective symptoms in relapsing-remitting multiple sclerosis. Compr Psychiatry 36: 390-395.
68. Nyenhuis DL, Rao SM, Zajecka JM, Luchetta T, Bernardin L, Garron DC (1995). Mood disturbance versus other symptoms of depression in multiple sclerosis. J Int Neuropsychol Sco 1: 291-296.
69. Ontiveros A, Fontaine R (1990). Panic attacks and multiple sclerosis. Biol Psychiatry 27: 672-673.
70. Pavlou M, Hartings M, Davis FA (1978). Discussion groups for medical patients. Psychother Psychsom 30: 105-115.
71. Pepper CM, Krupp LB, Friedberg F, Doscher C, Coyle PK (1993). A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis, and major depression. J Neuropsychiatry Clin Neurosci 5: 200-205.
72. Perez-Stable E, Miranda J, Munoz R, Ying Y-W (1990). Depression in medical outpatients: Underrecognition and misdiagnosis. Arch Int Med 150: 1083-1088.
73. Peselow ED, Fieve RR, Deutsch SI, Kaufman M (1981). Coexistent manic symptoms and multiple sclerosis. Psychosomatics 22: 824-825.
74. Poeck K (1969). Pathophysiology of emotional disorders associated with brain damage. In: Handbook of Clinical Neurology. Vinken PJ, Bruyn GW (eds). North Holland Publishing Co: Amsterdam. pp. 227-231.
75. Pratt RTC (1951). An investigation of the psychiatric aspects of disseminated sclerosis. J Neurol Neurosurg Psychiatry 14: 326-335.
76. Pujol J, Bello J, Deus J, Marti-Vilalta JL, Capdevila A (1997). Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis. Neurology 49: 1105-1110.
77. Rabins PV, Brooks BR, O'Donnell P, Pearlson GD, Moberg P, Jubelt B, Coyle P, Dalos N, Folstein MF (1986). Structural brain correlates of emotional disorder in multiple sclerosis. Brain 109: 585-597.
78. Rao SM, Leo GJ, Ellington I, Naurtz T, Bernardin I, Unverzagt F (1991). Cognitive dysfunction in multiple sclerosis. Neurology 41: 692-696.
79. Reiman EM (1997). Anxiety. In The Practitioner's Guide to Psychoactive Drugs. 4th edn. Gelenberg AJ and Bassuk EL (eds). Plenum Medical Book Company: New York, pp. 213-264.
80. Robinson RG, Parikh RM, Lipsey JR, Starkstein SE, Price TR (1993). Pathological laughing and crying following stroke: validation of a measurement scale and double-blind treatment study. Am J Psychiatry 150: 286-293.
81. Sabatini U, Pozzilli C, Pantano P, Koudriavtseva T, Padovani A, Millefiorini E, Di Biasi C, Gualdi GF, Salvetti M, Lenzi GL (1996). Involvement of the limbic system in multiple sclerosis patients.
82. Sackheim HA, Greenberg MS, Weinman AL, Gur RC, Hungerbuhler JP, Geschwind N (1982). Hemisphere asymmetry in the expression of positive and negative emotions. Neurological evidence. Arch Neurol 39: 210-218.
83. Sadovnick AD, Remick RA, Allen J, Swartz E, Yee IM, Eisen K, Farquhar R, Hashimoto SA, Hooge J, Kastrukoff LF, Morrison W, Nelson J, Oger J, Paty DW (1996). Depression and multiple sclerosis. Neurology 46: 628-632.
84. Salloway S, Price LH, Charney DS, Shapiro M (1988). Multiple sclerosis presenting as major depression, a diagnosis suggested by MRI scan but not by CT scan. J Clin Psychiatry 49: 364-366.
85. Sandyk R, Awerbuch GI (1993). Nocturnal melatonin secretion in multiple sclerosis patients with affective disorders. Int J Neurosci 68: 227-240.
86. Schiffer RB, Wineman NM (1990). Antidepressant pharmacotherapy of depression associated with multiple sclerosis. Am J Psychiatry 147: 1493-1497.
87. Schiffer RB, Babigian HM (1984). Behavioral disorders in multiple sclerosis, temporal lobe epilepsy, and amyotrophic lateral sclerosis, an epidemiologic study. Arch Neurol 41: 1067-1069.
88. Schiffer RB, Caine ED, Bamford KA, Levy S (1983). Depressive episodes in patients with multiple sclerosis. Am J Psychiatry 140: 1498-1500.
89. Schiffer RB, Caine ED (1991). The interaction between depressive affective disorder and neuropsychological test performance in multiple sclerosis patients. J Neuropsychiatry Clin Neurosci 3: 28-32.
90. Schiffer RB, Herndon RM, Rudick RA (1985). Treatment of pathologic laughing and weeping with amitriptyline. N Engl J Med 312: 1480-1482.
91. Schiffer RB (1987). The spectrum of depression in multiple sclerosis. An approach for clinical management. Arch Neurol 44: 596-599.
92. Schiffer RB, Weitkamp LR, Wineman NM, Guttormsen S (1988). Multiple sclerosis and aaffective disorder, family history, sex, and HLA-DR antigens. Arch Neurol 45: 1345-1348.
93. Schiffer RB, Wineman NM, Weirkamp LR (1986). Association between bipolar affective disorder and multiple sclerosis. Am J Psychiatry 143: 94-95.
94. Schubert DS, Foliart RH (1993). Increased depression in multiple sclerosis. A meta-analysis. Psychosomatics 34: 124-130.
95. Schulberg H, Saul M, McClelland M, Ganguli M, Christy W, Frank R (1985). Assessing depression in primary medical and psychiatric practice. Arch Gen Psychiatry 42: 1164-1170.
96. Schulberg HC, Rush JA (1994). Clinical practice guidelines in managing major depression in primary care practice. Am Psychologist 49: 34-41.
97. Schwartz CE, Coulthard-Morris L, Zeng Q (1996). Psychosocial correlates of fatigue in multiple sclerosis. Arch Phys Med Rehabil 77: 165-170.
98. Scott TF, Allen D, Price TR, McConnell H, Lang D (1996). Characterization of major depression symptoms in multiple sclerosis patients. J Neuropsychiatry Clin Neurosci 8: 318-323.
99. Scott TF, Nussbaum P, McConnell H, Brill P (1995). Measurement of treatment response to sertraline in depressed multiple sclerosis using the Carroll scale. Neurol Res 17: 421-422.
100. Seliger GM, Hornstein A, Flax J, Herbert J, Schroeder K (1992). Fluoxetine improves emotional incontinence. Brain Injury 6: 267-270.
101. Silver JM, Hales RE, Yudofsky SC (1990). Psychopharmacology of depression in neurologic disorders. J Clin Psychiatry 51 (Suppl): 31-39.
102. Skegg K, Corwin PA, Skegg DCG (1988). How often is multiple sclerosis mistaken for a psychiatric disorder? Psychol Med 18: 733-736.
103. Solomon J (1978). Multiple sclerosis masquerading as lithium toxicity. J Nerv Ment Dis 166: 663-665.
104. Spitzer RL, Kroenke K, Linzer M, Hahn SR, Williams JBW, Verloin deGruy III F, Brody D, Davies M (1995). Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 study. JAMA 274: 1511-1517.
105. Stenager E, Knudsen L, Jensen K (1989). Correlation of Beck depression Inventory score, Kurtzke disability status scale and cognitive functioning in multiple sclerosis. In Mental disorders and cognitive deficits in multiple sclerosis. Jensen K, Knudsen I, Stenager E, Grant I (eds). John Libbey & Co: London, pp. 147-151.
106. Stenager E, Knudsen L, Jensen K (1994). Multiple sclerosis: correlation of anxiaety, physicial impairment and cognitive dysfunction. Ital J Neurol Sci 15: 97-101.
107. Stenager E, Knudsen L, Jensen K (1991). Multiple sclerosis: the impact of physical impairment and cognitive dysfunction on social and sparetime activities. Psychother Psychosom 56: 123-138.
108. Stenager EN, Koch-Henriksen N, Stenager E (1996). Risk factors for suicide in multiple sclerosis. Psychother Psychosom 65: 86-90.
109. Sternberg EM, Gold PW (1994). Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function. J Clin Endocrinol. Metab 79: 848-853.
110. Sugar C, Nadell R (1943). Mental symptoms in multiple sclerosis. J Nerv Ment Dis 98: 267-280.
111. Sullivan MJ, Weinshenker B, Mikail S, Bishop SR (1995). Screening for major depression in the early stages of multiple sclerosis. Can J Neurol Sci 22: 228-231.
112. Surridge D (1969). An investigation into some psychiatric aspects of multiple sclerosis. Br J Psychiatry 115: 749-764.
113. Tatemichi TK, Nichols FT, Mohr JP (1987). Pathological crying: a pontine pseudobulbar syndrome [abstract]. Ann Neurol 22: 133.
114. Tedman BM, Young CA, Williams IR (1997). Assessment of depression in patients with motor neuron disease and other neurologically disabling illness. J Neurol Sci 152 (Suppl 1): S75-S79.
115. Tomsyck RR, Jenkins PL (1987). Psychiatric aspects of multiple sclerosis [clinical conference]. Gen Hosp Psychiatry 9: 294-301.
116. Tsolaki M, Drevelegas A, Karachristianous, Kapinas K, Divanoglou D, Routsonis K (1994). Correlation of dementia, neuropsychological and MRI findings in multiple sclerosis. Dementia 5: 48-52.
117. Udaka F, Yamao S, Nagata H, Nakamura A, Kameyama M (1984). Pathologic laughing and crying treated with levodopa. Arch Neurol 41: 1095-1096.
118. Weissman MM (1979). The psychological treatment of depression. Evidence for the efficacy of psychotherapy alone, in comparison with, and in combination with pharmacotherapy. Arch Gen Psychiatry 36: 1261-1269.
119. Whitlock FA, Siskind MM (1980). Depression as a major symptom of multiple sclerosis. J Neurol Neurosurg Psychiatry 43: 861-865.
120. Wolf JK, Santana HB, Thorpy M (1979). Treatment of 'emotional incontinence' with levodopa. Neurology 29: 1435-1436.
121. Yarnell PR (1987). Pathological crying localization [abstract]. Ann Neurol 22: 133.